TRACON Pharmaceuticals Inc (TCON)
1.79
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
1.79
0.00 (0.00%)
After-Hours: 20:00
TRACON Pharmaceuticals Cash from Financing (Quarterly): 1.324M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.324M |
| September 30, 2023 | -9.091M |
| June 30, 2023 | 1.048M |
| March 31, 2023 | -5.82M |
| December 31, 2022 | 4.945M |
| September 30, 2022 | 10.47M |
| June 30, 2022 | 4.959M |
| March 31, 2022 | -0.686M |
| December 31, 2021 | -0.706M |
| September 30, 2021 | 12.75M |
| June 30, 2021 | -0.628M |
| March 31, 2021 | -0.86M |
| December 31, 2020 | 13.31M |
| September 30, 2020 | 16.27M |
| June 30, 2020 | 4.174M |
| March 31, 2020 | 3.014M |
| December 31, 2019 | 1.602M |
| September 30, 2019 | -0.70M |
| June 30, 2019 | 0.024M |
| March 31, 2019 | -0.02M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.015M |
| September 30, 2018 | -0.016M |
| June 30, 2018 | 1.041M |
| March 31, 2018 | 34.28M |
| December 31, 2017 | 0.919M |
| September 30, 2017 | 2.53M |
| June 30, 2017 | 0.001M |
| March 31, 2017 | -0.124M |
| December 31, 2016 | 15.29M |
| September 30, 2016 | 4.00M |
| June 30, 2016 | 0.121M |
| March 31, 2016 | 0.007M |
| December 31, 2015 | 2.074M |
| September 30, 2015 | 0.039M |
| June 30, 2015 | -0.753M |
| March 31, 2015 | 35.09M |
| December 31, 2014 | -1.011M |
| September 30, 2014 | 27.20M |
| June 30, 2014 | 4.843M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-9.091M
Minimum
Sep 2023
16.27M
Maximum
Sep 2020
2.916M
Average
1.324M
Median
Dec 2023
Cash from Financing (Quarterly) Benchmarks
| BioSig Technologies Inc | 2.747M |
| Revolution Medicines Inc | 839.35M |
| Perspective Therapeutics Inc | 0.352M |
| Electromed Inc | 0.026M |
| Xtant Medical Holdings Inc | 0.325M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.522M |
| Free Cash Flow | 3.676M |
| Free Cash Flow Per Share (Quarterly) | -0.2637 |
| Free Cash Flow to Equity (Quarterly) | -0.522M |
| Free Cash Flow Yield | 125.5% |